Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery.

Trial Profile

Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Cognition disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Feb 2011 Planned End Date (1 Oct 2012) added as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Planned initiation date (1 Oct 2010) added as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top